Huntsman Ronald Kirk 4
4 · Vivos Therapeutics, Inc. · Filed Jun 15, 2023
Insider Transaction Report
Form 4
Huntsman Ronald Kirk
DirectorChief Executive Officer10% Owner
Transactions
- Purchase
Common Stock
2023-06-14$0.49/sh+10,000$4,900→ 57,500 total
Holdings
- 1,740,000(indirect: See footnote)
Common Stock
Footnotes (1)
- [F1]Shares held by Coronado V Partners, LLC, of which the reporting person is a member and manager.